中国临床药学杂志

参考文献

[1]中华医学会结核病学分会.非结核分枝杆菌病诊断与治疗指南(2020年版)[J].中华结核和呼吸杂志, 2020, 43(11):918.

[2]陈玥,戴书玥,刘磊.脓肿分枝杆菌复合群致人工关节置换术后假体周围感染的文献分析[J].临床药物治疗杂志, 2022, 20(2):67.

[3]林素梅,曾尚勇. 1例脓肿分枝杆菌致跟骨骨髓炎的药学监护[J].中南药学, 2020, 18(1):131.

[4]戴维·吉尔伯特.桑福德抗微生物治疗指南（新译第50版）[M].范洪伟，译.北京:中国协和医科大学出版社, 2021:154-160.

[5]雷朝勇,李兴,吴福山,等.假体隆乳术后脓肿分枝杆菌感染一例[J].中华整形外科杂志, 2021, 37(11):1271.

[6] GUO Y J, CAO X W, YU J Y, et al. Antimicrobial susceptibility of Mycobacterium abscessus complex clinical isolates from a Chinese tertiary hospital[J]. Infect Drug Resist, 2020, 13:2001.

[7] ZHANG Y S, MANN L B, WILSON R W, et al. Molecular analysis of Mycobacterium kansasii isolates from the United States[J]. J Clin Microbiol, 2004, 42(1):119.

[8]魏戌,谢雁鸣.国内外不良反应因果判断原则及评价方法解读[J].中国中药杂志, 2012, 37(18):2744.

[9] YAGHOUBI S, ZEKIY A O, KRUTOVA M, et al. Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance:narrative review[J]. Eur J Clin Microbiol Infect Dis, 2022,41(7):1003.

[10] MEAGHER A K, PASSARELL J A, CIRINCIONE B B, et al.Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections[J]. Antimicrob Agents Chemother, 2007, 51(6):1939.

[11] FERRO B E, SRIVASTAVA S, DESHPANDE D, et al. Tigecycline is highly efficacious against mycobacterium abscessus pulmonary d i s e a s e[J]. A n t i m i c r o b A g e n t s C h e m o t h e r, 2 0 1 6, 6 0(5):2895.

[12]白延宁,王莉,孙宝,等.利奈唑胺不良反应的文献统计分析[J].中国医院药学杂志, 2022, 42(20):2166.

[13] GORDI T, TAN L H, HONG C, et al. The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E[J]. J Clin Pharmacol, 2003, 43(10):1161.

[14]钟玲,邵华,陈燕,等.利奈唑胺诱导血小板减少症的研究进展[J].中国临床药理学与治疗学, 2018, 23(10):1196.

[15] TAKAHASHI Y, TAKESUE Y, NAKAJIMA K, et al. Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy[J]. J Infect Chemother, 2011,17(3):382.